In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation

被引:68
作者
Chin, PL
Momand, J
Pfeifer, GP
机构
[1] CITY HOPE NATL MED CTR, DEPT BIOL, DUARTE, CA 91010 USA
[2] CITY HOPE NATL MED CTR, DEPT CELL & TUMOR BIOL, DUARTE, CA 91010 USA
关键词
p53; p21; GADD45; MDM2; radiation;
D O I
10.1038/sj.onc.1201161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein p53 has a transcriptional activation activity thought to mediate its biologic function including G(1) arrest and perhaps apoptosis, To learn more about p53's transactivator function in vivo, we performed genomic footprinting experiments examining p53-DNA interactions in the regulatory regions of the p53-regulated genes p21, GADD45, and MDM2. Using ionizing radiation to induce DNA damage in human ML-1 myeloblastic leukemia cells, the promoter and intronic regions of these genes containing p53-consensus binding sites were examined for in vivo footprints, There was a uniform and sustained expression of p53 protein as well as a strong induction of p21, GADD45, and MDM2 mRNA following irradiation, At the two p53 consensus binding sites in the p21 promoter, reduced DNaseI cleavage was observed in irradiated cells beginning 1 to 2 h after irradiation, being most checkpoints, pronounced after 2 h and diminishing after 8 h. A partial interest. in vivo footprint was also observed in the third intron of the GADD45 gene beginning 2 h after irradiation, No in vivo footprints were seen at the two p53 binding sites in the MDM2 gene, Our study provides direct evidence that the DNA damage-induced activity of p53 is mediated by its consensus DNA binding sites in the p21 and GADD45 genes, We suggest that the transient nature and relative instability of p53-DNA interactions in vivo may make the p53 protein more accessible to a rapid turnover pathway which might be impaired under conditions when the protein is stably bound to DNA.
引用
收藏
页码:87 / 99
页数:13
相关论文
共 67 条
[31]   UV IRRADIATION STIMULATES LEVELS OF P53 CELLULAR TUMOR-ANTIGEN IN NONTRANSFORMED MOUSE CELLS [J].
MALTZMAN, W ;
CZYZYK, L .
MOLECULAR AND CELLULAR BIOLOGY, 1984, 4 (09) :1689-1694
[32]  
Maxam A M, 1980, Methods Enzymol, V65, P499
[33]  
Mayo LD, 1996, ONCOGENE, V13, P2315
[34]  
MICHIELI P, 1994, CANCER RES, V54, P3391
[35]  
Moll UM, 1996, MOL CELL BIOL, V16, P1126
[36]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[37]  
Momand J, 1996, ONCOGENE, V12, P2279
[38]  
Momand J, 1997, J CELL BIOCHEM, V64, P343
[39]  
MOSNER J, 1994, ONCOGENE, V9, P3321
[40]   INVIVO FOOTPRINTING OF A MUSCLE SPECIFIC ENHANCER BY LIGATION MEDIATED PCR [J].
MUELLER, PR ;
WOLD, B .
SCIENCE, 1989, 246 (4931) :780-786